Increase in research and development activities, rapid increase in genetic testing, and favorable reimbursement policies regarding medical tests are some key factors expected to drive market growth
According to Emergen Research, the global reproductive genetics market size was USD 4.41 billion in 2020 and is expected to reach USD 11.23 billion in 2028 and register a revenue CAGR of 12.3% during the forecast period, 2021-2028.
Reproductive genetics deals with the relationship between the reproduction and genotype. This includes researching how genetic material and epigenetic alterations are passed down from generation to next generation during a pregnancy. It refers to the genetic tests and procedures that provides information regarding the possibility of parents passing a genetic mutation to their offspring; identification of the infertility causes, and information about the genetic traits of embryos produced through IVF. This information helps individuals to take informed decisions regarding medical and lifestyle decisions, and assess risks for common chromosomal disorders. These key factors are expected to drive market revenue growth during the forecast period.
Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/695
Further, rising awareness for genetic testing and screening along with technical improvements is expected to further fuel market revenue growth. In addition, increasing government and private investments in advancements in genomic technologies to support diagnosis of genetic disorders, and early identification of infertility causes are some major factors expected to drive market growth over the forecast period.
However, high cost of testing, inappropriate treatment, and lack of regulations and after effects of reproductive genetics testing can hamper market growth to a certain extent over the forecast period. For instance, testing increase stress and anxiety for some individuals, and causes negative impact on personal and family relationships.
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
In-Situ Hybridization Segment Revenue to Expand at a Rapid CAGR:
In-situ hybridization segment is expected to register a rapid revenue CAGR over the forecast period attributed to rising number of patients suffering from genetic disorders and cancer and increasing awareness about companion diagnostics tests in In-situ hybridization (ISH).
Check Our Prices@ https://www.emergenresearch.com/select-license/695
Single Gene Disorders Segment to Register Significant Revenue Growth:
Single gene disorders segment is expected to register significant revenue growth over the forecast period. Due to their inheritance patterns and relatively simple genetic causes, single gene illnesses are among the most-understood genetic disorders. Cystic fibrosis, sickle cell anaemia, hemochromatosis, and Tay-Sachs are some of the most frequent single gene disorders. Single gene disorders in infants can be detected by reproductive genetic testing.
North America to Account for Largest Revenue Share:
North America is expected to account for largest revenue share in the global market over the forecast period due to rapid adoption of genomic techniques, advanced healthcare infrastructure, and presence of key market players in the region. Further, increasing utilization of In-Vitro Fertilization (IVF) procedures along with technological advancements are also expected to fuel revenue growth of the North America market.
Major Companies in the Market Include:
- Illumina, Inc.
- Agilent Technologies, Inc.
- PerkinElmer, Inc.
- Quest Diagnostics
- Thermo Fisher Scientific Inc.
- Fulgent Genetics, Inc.
- Centogene AG
- Myriad Genetics, Inc.
- Qiagen N.V.
- OPKO Health, Inc.
For the purpose of this report, Emergen Research has segmented the global reproductive genetics market on the basis of product type, procedure type, technology, application, and region:
Product Type Outlook (Revenue, USD Billion; 2018–2028)
- Laboratory Developed Tests (LDT)
- Reagents and Consumables
Procedure Type Outlook (Revenue, USD Billion; 2018–2028)
- Pre-Natal Screening
- Pre-Implantation Genetic Testing
- Infertility Genetic Testing
- Carrier Screening
Technology Outlook (Revenue, USD Billion; 2018–2028)
- Next-Generation Sequencing (NGS)
- Polymerase chain reaction (PCR)
- In-Situ Hybridization (ISH)
Application Outlook (Revenue, USD Billion; 2018–2028)
- Single Gene Disorder
- Structural Chromosomal Abnormality
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/reproductive-genetics-market
Regional Outlook (Revenue, USD Million; 2018–2028)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
Take a Look at our Related Reports:
Autorefractor Market Analysis By Product Type (Retinoscopes, OCT Scanners, Corneal Topography Systems, Ophthalmoscopes, Others), By Application (Myopia, Hyperopia, Others), By End-User (Hospitals, Ophthalmic Clinics, Diagnostic Centers), By Region, Forecast To 2027
Drug Discovery Services Market Analysis By Process (Target Selection, Target Validation, Lead Optimization, Candidate Validation, Others), By Type (Medicinal Chemistry, Biology Services, Pharmacokinetics & Drug Metabolism), By Drug Type (Biologics, Small Molecules), By Therapeutic Area (Neurology, Diabetes, Oncology, Others), By End-user (Hospital & Clinics, Pharmaceutical & Biotech Companies, Others), By Region, Forecast to 2027
Wound Cleanser Products Market By Product Type (Wetting Agents, Antiseptics, Moisturizers, Others), By Form Type (Sprays, Solutions, Wipes, Foams, Others), By End User (Hospitals, Ambulatory Surgery Centers, Pharmacies and Clinics, Homecare Settings) and By Regions Forecasts to 2027
Flexible Sigmoidoscopy Market Analysis By Product Type (Flexible Sigmoidoscope, Rigid Sigmoidoscope), By Application (Monitoring, Diagnosis, Others), By End-User (Hospitals, Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Gastroenterology Institutes, Others), By Region, Forecast To 2027
Hydralazine Market Analysis By Type (Tablet, Injection), By Application (Hospital, Clinics, Diagnostic Centers, Recovery Centers, Others), By End Use, By Region, Forecast to 2027
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
Read Full Press Release: https://www.emergenresearch.com/press-release/global-reproductive-genetics-market